Cargando…
Molecular Network Approach Reveals Rictor as a Central Target of Cardiac ProtectomiRs
Cardioprotective medications are still unmet clinical needs. We have previously identified several cardioprotective microRNAs (termed ProtectomiRs), the mRNA targets of which may reveal new drug targets for cardioprotection. Here we aimed to identify key molecular targets of ProtectomiRs and confirm...
Autores principales: | Makkos, András, Ágg, Bence, Varga, Zoltán V., Giricz, Zoltán, Gyöngyösi, Mariann, Lukovic, Dominika, Schulz, Rainer, Barteková, Monika, Görbe, Anikó, Ferdinandy, Péter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430799/ https://www.ncbi.nlm.nih.gov/pubmed/34502448 http://dx.doi.org/10.3390/ijms22179539 |
Ejemplares similares
-
Cardiac miRNA Expression and their mRNA Targets in a Rat Model of Prediabetes
por: Sághy, Éva, et al.
Publicado: (2020) -
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021) -
In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature
por: Baranyai, Tamás, et al.
Publicado: (2017) -
Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications
por: Ferdinandy, Péter, et al.
Publicado: (2019) -
Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity
por: Gergely, Tamás G., et al.
Publicado: (2023)